Rani Therapeutics Holdings Inc. (RANI)
NASDAQ · Healthcare
Rani Therapeutics Holdings Inc. EPS 2020–2025
Rani Therapeutics Holdings Inc. annual/quarterly eps history and growth rate from 2021 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Rani Therapeutics Holdings Inc. eps for the quarter ending March 31, 2026 was $0.04, a 81.82% decrease year-over-year.
- Rani Therapeutics Holdings Inc. annual eps for 2025 was $0.45, a 57.14% decrease from 2024.
- Rani Therapeutics Holdings Inc. annual eps for 2024 was $1.05, a 21.05% decrease from 2023.
- Rani Therapeutics Holdings Inc. annual eps for 2023 was $1.33, a 3.91% increase from 2022.
- Rani Therapeutics Holdings Inc. annual eps for 2022 was $1.28.
EPS
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Rani Therapeutics Holdings Inc. EPS — FAQ
Rani Therapeutics Holdings Inc. (RANI) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Rani Therapeutics Holdings Inc.'s eps?
Rani Therapeutics Holdings Inc. (RANI) reported eps of $-0.45 for fiscal 2025.
Where can I see RANI's eps history?
The chart and table above show Rani Therapeutics Holdings Inc.'s eps by year and by quarter, including the growth rate.